// App-Quantinova.ai

187 : Patient-reported Outcomes and Quality of Life in Patients with Rheumatoid Arthritis Treated with GP2015: Final Results from a Real-world Study

Researchers

Presenter

  • Sohaib Hachaichi

Principal Investigators

  • Ayman Askari

  • Marc Schmalzing

  • Herbert Kellner

  • Rafaela Ortega-Castro

  • Julio Cesar Vázquez Perez-Coleman

  • Foti Rosario

  • Sławomir Jeka

  • Boulos Haraoui

  • Yannick Allanore

  • Masiur Rahman

  • Fabricio Furlan

  • Tom Sheeran

Medical Centers

  • The Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, United Kingdom

  • University of Wurzburg, Wurzburg, Germany

  • Schwerpunktpraxis fur Rheumatologie und Gastroenterologie Munich, Munich, Germany

  • University of Cordoba/IMIBIC/Reina Sofia Hospital, Cordoba, Spain

  • University Hospital Complex of Ferrol, A Coruña, Spain

  • Policlinico G. Rodolico-S.Marco Hospital, Catania, Italy

  • University Hospital No 2 in Bydgoszcz Collegium Medicum UMK, Clinic and Department of Rheumatology and Connective Tissue Diseases, Bydgoszcz, Poland

  • Institut de Rhumatologie, Montreal, QC, Canada

  • Dept. of Rheumatology A, Descartes University, APHP, Cochin Hospital, Paris, France, Paris, France

  • Sandoz/ Hexal AG, Holzkirchen, Germany

  • Hexal AG, a Sandoz company, Holzkirchen, Germany

  • New Cross and Cannock Chase Hospitals, University of Wolverhampton, Cannock, United Kingdom

Locations

  • Chile

  • United Kingdom

  • Germany

  • Spain

  • Italy

  • Poland

  • Canada

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • GP2015

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A